Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 114–114 | Cite as

Dasatinib

Death: case report
Case report
  • 10 Downloads

Reference

  1. Kurosawa H, et al. Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric Blood and Cancer 65: e27368, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1002/pbc.27368 - Japan

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations